

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 5.66607203 |
| 2 | polyketide metabolic process (GO:0030638) | 5.66607203 |
| 3 | doxorubicin metabolic process (GO:0044598) | 5.66607203 |
| 4 | oligosaccharide catabolic process (GO:0009313) | 4.82602113 |
| 5 | melanin biosynthetic process (GO:0042438) | 4.68484079 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.43530541 |
| 7 | adhesion of symbiont to host (GO:0044406) | 4.34858683 |
| 8 | regulation of mononuclear cell migration (GO:0071675) | 4.32048133 |
| 9 | sphingolipid catabolic process (GO:0030149) | 4.26710576 |
| 10 | membrane lipid catabolic process (GO:0046466) | 4.22043664 |
| 11 | secondary metabolite biosynthetic process (GO:0044550) | 4.05849506 |
| 12 | melanin metabolic process (GO:0006582) | 3.97607237 |
| 13 | plasma lipoprotein particle clearance (GO:0034381) | 3.73891455 |
| 14 | regulation of cholesterol esterification (GO:0010872) | 3.64840064 |
| 15 | N-acetylneuraminate metabolic process (GO:0006054) | 3.45255716 |
| 16 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.42382124 |
| 17 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.38011397 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30380318 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.30380318 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30380318 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30380318 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30380318 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.30380318 |
| 24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.30235706 |
| 25 | glycoside metabolic process (GO:0016137) | 3.29437811 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.23803598 |
| 27 | protein carboxylation (GO:0018214) | 3.21641934 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.21641934 |
| 29 | lytic vacuole organization (GO:0080171) | 3.18935427 |
| 30 | lysosome organization (GO:0007040) | 3.18935427 |
| 31 | keratan sulfate catabolic process (GO:0042340) | 3.15250328 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.14129156 |
| 33 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.11281117 |
| 34 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.11281117 |
| 35 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.10388051 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09539861 |
| 37 | low-density lipoprotein particle clearance (GO:0034383) | 3.09181194 |
| 38 | pinocytosis (GO:0006907) | 3.08715049 |
| 39 | cytidine metabolic process (GO:0046087) | 3.08544947 |
| 40 | cytidine catabolic process (GO:0006216) | 3.08544947 |
| 41 | cytidine deamination (GO:0009972) | 3.08544947 |
| 42 | barbed-end actin filament capping (GO:0051016) | 3.05958683 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.02504303 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.02504303 |
| 45 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.01834637 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 2.99664031 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98510501 |
| 48 | cholesterol efflux (GO:0033344) | 2.97514639 |
| 49 | apoptotic cell clearance (GO:0043277) | 2.96546237 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.96032286 |
| 51 | regulation of macrophage chemotaxis (GO:0010758) | 2.92686974 |
| 52 | phospholipid efflux (GO:0033700) | 2.92336979 |
| 53 | fibrinolysis (GO:0042730) | 2.91478593 |
| 54 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.91242214 |
| 55 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90536231 |
| 56 | tyrosine metabolic process (GO:0006570) | 2.88617525 |
| 57 | amino sugar catabolic process (GO:0046348) | 2.88356065 |
| 58 | regulation of apoptotic cell clearance (GO:2000425) | 2.88215492 |
| 59 | mannose metabolic process (GO:0006013) | 2.87771183 |
| 60 | endosome to pigment granule transport (GO:0043485) | 2.87564182 |
| 61 | endosome to melanosome transport (GO:0035646) | 2.87564182 |
| 62 | negative regulation of fibrinolysis (GO:0051918) | 2.85686879 |
| 63 | response to peptidoglycan (GO:0032494) | 2.84528323 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.83081691 |
| 65 | hyaluronan catabolic process (GO:0030214) | 2.83058618 |
| 66 | complement activation, alternative pathway (GO:0006957) | 2.82722572 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.77320472 |
| 68 | monocyte chemotaxis (GO:0002548) | 2.76555321 |
| 69 | regulation of fibrinolysis (GO:0051917) | 2.75024311 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 2.74772358 |
| 71 | phagocytosis, recognition (GO:0006910) | 2.74058926 |
| 72 | regulation of superoxide anion generation (GO:0032928) | 2.73787855 |
| 73 | regulation of cholesterol storage (GO:0010885) | 2.73746132 |
| 74 | amyloid precursor protein catabolic process (GO:0042987) | 2.72916400 |
| 75 | cyclooxygenase pathway (GO:0019371) | 2.71295844 |
| 76 | muscle organ morphogenesis (GO:0048644) | 2.69497471 |
| 77 | negative regulation of sterol transport (GO:0032372) | 2.69376729 |
| 78 | negative regulation of cholesterol transport (GO:0032375) | 2.69376729 |
| 79 | eosinophil chemotaxis (GO:0048245) | 2.64991719 |
| 80 | skin morphogenesis (GO:0043589) | 2.63586737 |
| 81 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.63126036 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62907445 |
| 83 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.60645218 |
| 84 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58686898 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.58027388 |
| 86 | L-phenylalanine catabolic process (GO:0006559) | 2.58027388 |
| 87 | hormone catabolic process (GO:0042447) | 2.56172378 |
| 88 | glycosylceramide metabolic process (GO:0006677) | 2.55360721 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 2.55034681 |
| 90 | negative regulation of coagulation (GO:0050819) | 2.54766984 |
| 91 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.54655604 |
| 92 | decidualization (GO:0046697) | 2.54590151 |
| 93 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.54220983 |
| 94 | glycosphingolipid metabolic process (GO:0006687) | 2.53476660 |
| 95 | primary alcohol catabolic process (GO:0034310) | 2.53125862 |
| 96 | sphingosine metabolic process (GO:0006670) | 2.51634614 |
| 97 | intestinal epithelial cell development (GO:0060576) | 2.50034800 |
| 98 | macrophage activation involved in immune response (GO:0002281) | 2.49584068 |
| 99 | glycosphingolipid catabolic process (GO:0046479) | 2.49365488 |
| 100 | interferon-gamma secretion (GO:0072643) | 2.49284724 |
| 101 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.47686063 |
| 102 | vitamin D metabolic process (GO:0042359) | 2.47550203 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46497109 |
| 104 | cofactor transport (GO:0051181) | 2.45769214 |
| 105 | intracellular pH reduction (GO:0051452) | 2.45761633 |
| 106 | regulation of chemokine biosynthetic process (GO:0045073) | 2.45265299 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.44330644 |
| 108 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.43922444 |
| 109 | modified amino acid transport (GO:0072337) | 2.43429266 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.42648273 |
| 111 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.42648273 |
| 112 | glial cell migration (GO:0008347) | 2.42637907 |
| 113 | cellular response to arsenic-containing substance (GO:0071243) | 2.42382494 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.41758230 |
| 115 | protein-lipid complex assembly (GO:0065005) | 2.41220148 |
| 116 | interferon-gamma production (GO:0032609) | 2.40939035 |
| 117 | regulation of monocyte chemotaxis (GO:0090025) | 2.39847685 |
| 118 | sulfur amino acid catabolic process (GO:0000098) | 2.39670573 |
| 119 | protein localization to endosome (GO:0036010) | 2.39462296 |
| 120 | peptide catabolic process (GO:0043171) | 2.39450821 |
| 121 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.39381355 |
| 122 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.38366850 |
| 123 | high-density lipoprotein particle remodeling (GO:0034375) | 2.38245218 |
| 124 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.38128698 |
| 125 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.35990763 |
| 126 | pH reduction (GO:0045851) | 2.35021159 |
| 127 | low-density lipoprotein particle remodeling (GO:0034374) | 2.34268304 |
| 128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.33957573 |
| 129 | glycolipid catabolic process (GO:0019377) | 2.33848665 |
| 130 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.33282364 |
| 131 | regulation of response to osmotic stress (GO:0047484) | 2.32645543 |
| 132 | response to pH (GO:0009268) | 2.32627898 |
| 133 | eosinophil migration (GO:0072677) | 2.32579275 |
| 134 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.32511694 |
| 135 | nucleoside transport (GO:0015858) | 2.30306329 |
| 136 | regulation of interferon-alpha production (GO:0032647) | 2.30171150 |
| 137 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.29454313 |
| 138 | nucleoside transmembrane transport (GO:1901642) | 2.28360217 |
| 139 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.26767173 |
| 140 | positive regulation of tissue remodeling (GO:0034105) | 2.26193466 |
| 141 | folic acid transport (GO:0015884) | 2.25859699 |
| 142 | phagocytosis, engulfment (GO:0006911) | 2.24704124 |
| 143 | cellular extravasation (GO:0045123) | 2.24368553 |
| 144 | regulation of chemokine secretion (GO:0090196) | 2.21804592 |
| 145 | diol metabolic process (GO:0034311) | 2.21551267 |
| 146 | signal peptide processing (GO:0006465) | 2.20205681 |
| 147 | ceramide catabolic process (GO:0046514) | 2.19492385 |
| 148 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.19289721 |
| 149 | respiratory burst (GO:0045730) | 2.18514796 |
| 150 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.15722103 |
| 151 | adhesion of symbiont to host cell (GO:0044650) | 2.15692224 |
| 152 | virion attachment to host cell (GO:0019062) | 2.15692224 |
| 153 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.15641016 |
| 154 | regulation of antigen processing and presentation (GO:0002577) | 2.15106280 |
| 155 | negative regulation of phagocytosis (GO:0050765) | 2.14990960 |
| 156 | wound healing, spreading of epidermal cells (GO:0035313) | 2.14932431 |
| 157 | L-ascorbic acid metabolic process (GO:0019852) | 2.14914802 |
| 158 | pentose-phosphate shunt (GO:0006098) | 2.14642854 |
| 159 | B cell mediated immunity (GO:0019724) | 2.14504447 |
| 160 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.14188629 |
| 161 | response to thyroid hormone (GO:0097066) | 2.14087208 |
| 162 | regulation of translation in response to stress (GO:0043555) | 2.13198868 |
| 163 | reactive oxygen species biosynthetic process (GO:1903409) | 2.12057304 |
| 164 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.11034319 |
| 165 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.09142587 |
| 166 | valine metabolic process (GO:0006573) | 2.06514316 |
| 167 | establishment of endothelial barrier (GO:0061028) | 2.06159951 |
| 168 | negative regulation of epidermis development (GO:0045683) | 2.05654367 |
| 169 | maintenance of protein location in nucleus (GO:0051457) | 2.05458958 |
| 170 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.05234422 |
| 171 | pentose metabolic process (GO:0019321) | 2.04156834 |
| 172 | basement membrane organization (GO:0071711) | 2.02728476 |
| 173 | response to laminar fluid shear stress (GO:0034616) | 2.02542105 |
| 174 | positive regulation of antigen processing and presentation (GO:0002579) | 2.02422157 |
| 175 | negative regulation of telomerase activity (GO:0051974) | 2.02107700 |
| 176 | positive regulation of chemokine secretion (GO:0090197) | 2.02007382 |
| 177 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.01725274 |
| 178 | myeloid cell homeostasis (GO:0002262) | 2.01167626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.03554233 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40903647 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12730754 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07731571 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.07728046 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.04244110 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.04244110 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.04244110 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.36884888 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.35107982 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08991514 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.92225283 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87822792 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.86584144 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85690039 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83770388 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81787836 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81422029 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77279478 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76048233 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66275474 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58610197 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58150093 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56775449 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55977699 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.54853371 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54668523 |
| 28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.54415132 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53784405 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53752650 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52157912 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51912688 |
| 33 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50102580 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46360283 |
| 35 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.46094987 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42507546 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42316113 |
| 38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42064539 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40728453 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38893338 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36809433 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34170789 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34040014 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33061663 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32688948 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31647466 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30980567 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30484700 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29593075 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29404749 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28260138 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28100764 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27073268 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26775620 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26755130 |
| 56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26113843 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25821624 |
| 58 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25799281 |
| 59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25148586 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25066047 |
| 61 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24661078 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24527866 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23232994 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.22629198 |
| 65 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20309072 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18326837 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17665319 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17280921 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16841795 |
| 70 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16777486 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16524613 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15911717 |
| 73 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.15528000 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12754765 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12120533 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12108350 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11921446 |
| 78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11748805 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11237898 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10728796 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10621207 |
| 82 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10514265 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10335193 |
| 84 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09776808 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09256838 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08914440 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08164203 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08075265 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07655517 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07563567 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07179271 |
| 92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06752133 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05142345 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04916199 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04055936 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03420880 |
| 97 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.02799174 |
| 98 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.02506917 |
| 99 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01230401 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00718471 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00127511 |
| 102 | P68_20966046_ChIP-Seq_HELA_Human | 0.99868144 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99535125 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97977366 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97681267 |
| 106 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97532224 |
| 107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97382487 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97207281 |
| 109 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97052969 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96858673 |
| 111 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96713943 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96544427 |
| 113 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.96343170 |
| 114 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96290848 |
| 115 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96222035 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96080665 |
| 117 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96079760 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95505216 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 0.95497858 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95389689 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95347097 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94233110 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93990269 |
| 124 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93798785 |
| 125 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93537848 |
| 126 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93329501 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92916115 |
| 128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92192701 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92012007 |
| 130 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91566098 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91521330 |
| 132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90777920 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89423142 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89362479 |
| 135 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88385403 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88209908 |
| 137 | MYB_26560356_Chip-Seq_TH2_Human | 0.87548598 |
| 138 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87072571 |
| 139 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.86916514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.92349542 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.75343952 |
| 3 | MP0005171_absent_coat_pigmentation | 3.25004907 |
| 4 | MP0003136_yellow_coat_color | 3.03263974 |
| 5 | MP0005408_hypopigmentation | 2.90634558 |
| 6 | MP0006082_CNS_inflammation | 2.83786800 |
| 7 | MP0009840_abnormal_foam_cell | 2.71734181 |
| 8 | MP0002254_reproductive_system_inflammat | 2.55318009 |
| 9 | MP0003011_delayed_dark_adaptation | 2.45813573 |
| 10 | MP0005365_abnormal_bile_salt | 2.30151019 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.25378632 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.22265490 |
| 13 | MP0003436_decreased_susceptibility_to | 2.18219864 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.16517173 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.09668173 |
| 16 | MP0000371_diluted_coat_color | 1.97594946 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 1.86725123 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.86398994 |
| 19 | MP0005360_urolithiasis | 1.85417460 |
| 20 | MP0009785_altered_susceptibility_to | 1.78011761 |
| 21 | MP0003186_abnormal_redox_activity | 1.71974872 |
| 22 | MP0002419_abnormal_innate_immunity | 1.69857856 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.68958699 |
| 24 | MP0000343_altered_response_to | 1.64967097 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.64959592 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.63699325 |
| 27 | MP0005025_abnormal_response_to | 1.63250449 |
| 28 | MP0000858_altered_metastatic_potential | 1.63203553 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.59514918 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.59417930 |
| 31 | MP0003075_altered_response_to | 1.55910901 |
| 32 | MP0005387_immune_system_phenotype | 1.54413099 |
| 33 | MP0001790_abnormal_immune_system | 1.54413099 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.53405441 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.52862589 |
| 36 | MP0005023_abnormal_wound_healing | 1.51090956 |
| 37 | MP0005451_abnormal_body_composition | 1.48147442 |
| 38 | MP0003724_increased_susceptibility_to | 1.43021498 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.42674579 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.39175627 |
| 41 | MP0003448_altered_tumor_morphology | 1.35339511 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.34744374 |
| 43 | MP0005671_abnormal_response_to | 1.34661471 |
| 44 | MP0002090_abnormal_vision | 1.34558173 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.33289762 |
| 46 | MP0001958_emphysema | 1.33057284 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.33034006 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.28499309 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.28292691 |
| 50 | MP0002405_respiratory_system_inflammati | 1.26003784 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.25353523 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25073181 |
| 53 | MP0004947_skin_inflammation | 1.24405193 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.23258167 |
| 55 | MP0002132_abnormal_respiratory_system | 1.22855859 |
| 56 | MP0001324_abnormal_eye_pigmentation | 1.21953463 |
| 57 | MP0000685_abnormal_immune_system | 1.21890373 |
| 58 | MP0001853_heart_inflammation | 1.21213485 |
| 59 | MP0002723_abnormal_immune_serum | 1.20989158 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.20262851 |
| 61 | MP0001800_abnormal_humoral_immune | 1.20197442 |
| 62 | MP0000490_abnormal_crypts_of | 1.20125259 |
| 63 | MP0004510_myositis | 1.18547171 |
| 64 | MP0003279_aneurysm | 1.18503990 |
| 65 | MP0001542_abnormal_bone_strength | 1.18383438 |
| 66 | MP0002075_abnormal_coat/hair_pigmentati | 1.17339647 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.15583589 |
| 68 | MP0001819_abnormal_immune_cell | 1.13685642 |
| 69 | MP0008469_abnormal_protein_level | 1.12529991 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.12298049 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.12219579 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.11651570 |
| 73 | MP0003303_peritoneal_inflammation | 1.10583959 |
| 74 | MP0005390_skeleton_phenotype | 1.10141444 |
| 75 | MP0005310_abnormal_salivary_gland | 1.10028646 |
| 76 | MP0009764_decreased_sensitivity_to | 1.07986606 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.07428577 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.07386645 |
| 79 | MP0005197_abnormal_uvea_morphology | 1.06251418 |
| 80 | MP0001186_pigmentation_phenotype | 1.06021797 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.04554021 |
| 82 | MP0003195_calcinosis | 1.03502804 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 1.02884763 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.00536723 |
| 85 | MP0008260_abnormal_autophagy | 1.00464256 |
| 86 | MP0002136_abnormal_kidney_physiology | 1.00228578 |
| 87 | MP0004858_abnormal_nervous_system | 0.99032443 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.97519098 |
| 89 | MP0004272_abnormal_basement_membrane | 0.96390330 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.95568561 |
| 91 | MP0005508_abnormal_skeleton_morphology | 0.95035910 |
| 92 | MP0002933_joint_inflammation | 0.93778121 |
| 93 | MP0005164_abnormal_response_to | 0.93355115 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.93212439 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.92739665 |
| 96 | MP0005332_abnormal_amino_acid | 0.91957781 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.91603023 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.91522330 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.90792328 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.89603394 |
| 101 | MP0000920_abnormal_myelination | 0.89423477 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.89336838 |
| 103 | MP0001756_abnormal_urination | 0.89115761 |
| 104 | MP0002938_white_spotting | 0.87716700 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.87176456 |
| 106 | MP0000716_abnormal_immune_system | 0.85347479 |
| 107 | MP0002722_abnormal_immune_system | 0.85243666 |
| 108 | MP0008004_abnormal_stomach_pH | 0.85130123 |
| 109 | MP0003795_abnormal_bone_structure | 0.83890108 |
| 110 | MP0000249_abnormal_blood_vessel | 0.83064375 |
| 111 | MP0006054_spinal_hemorrhage | 0.82949729 |
| 112 | MP0004381_abnormal_hair_follicle | 0.82690325 |
| 113 | MP0000604_amyloidosis | 0.82144958 |
| 114 | MP0000609_abnormal_liver_physiology | 0.81825476 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.81584337 |
| 116 | MP0001243_abnormal_dermal_layer | 0.81457018 |
| 117 | MP0003329_amyloid_beta_deposits | 0.80697863 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.80240386 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.80070106 |
| 120 | MP0002095_abnormal_skin_pigmentation | 0.80034217 |
| 121 | MP0002429_abnormal_blood_cell | 0.79653746 |
| 122 | MP0001849_ear_inflammation | 0.76942009 |
| 123 | MP0005165_increased_susceptibility_to | 0.74474988 |
| 124 | MP0002060_abnormal_skin_morphology | 0.74463514 |
| 125 | MP0003828_pulmonary_edema | 0.73611081 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.73526357 |
| 127 | MP0004883_abnormal_blood_vessel | 0.72958924 |
| 128 | MP0005503_abnormal_tendon_morphology | 0.72858355 |
| 129 | MP0010030_abnormal_orbit_morphology | 0.72826274 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.72772202 |
| 131 | MP0000767_abnormal_smooth_muscle | 0.70908061 |
| 132 | MP0003634_abnormal_glial_cell | 0.70245685 |
| 133 | MP0000598_abnormal_liver_morphology | 0.69828958 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.69146475 |
| 135 | MP0001764_abnormal_homeostasis | 0.69100870 |
| 136 | MP0003690_abnormal_glial_cell | 0.68498004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.78795242 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.88976637 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.88976637 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.88976637 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.21120504 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.04667683 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.01395748 |
| 8 | Nuclear cataract (HP:0100018) | 3.94823027 |
| 9 | Complement deficiency (HP:0004431) | 3.44404223 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.36573125 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.36390452 |
| 12 | Mucopolysacchariduria (HP:0008155) | 3.36390452 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.31228150 |
| 14 | Multiple enchondromatosis (HP:0005701) | 3.13006094 |
| 15 | Cervical subluxation (HP:0003308) | 3.12664157 |
| 16 | Premature rupture of membranes (HP:0001788) | 3.12515129 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.09970985 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.09970985 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.09970985 |
| 20 | Bilateral microphthalmos (HP:0007633) | 3.05860283 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.04293209 |
| 22 | Abnormality of complement system (HP:0005339) | 2.95967124 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.87845350 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.86398465 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84117116 |
| 26 | Disinhibition (HP:0000734) | 2.82005961 |
| 27 | White forelock (HP:0002211) | 2.77230847 |
| 28 | Patchy hypopigmentation of hair (HP:0011365) | 2.73641618 |
| 29 | J-shaped sella turcica (HP:0002680) | 2.64707735 |
| 30 | Pustule (HP:0200039) | 2.63614215 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.63127536 |
| 32 | Axonal loss (HP:0003447) | 2.62939446 |
| 33 | Cheilitis (HP:0100825) | 2.62168837 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.61301578 |
| 35 | Mutism (HP:0002300) | 2.61262141 |
| 36 | Poor head control (HP:0002421) | 2.57106475 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.56760380 |
| 38 | Trismus (HP:0000211) | 2.55995246 |
| 39 | Reduced antithrombin III activity (HP:0001976) | 2.50056901 |
| 40 | Retinal atrophy (HP:0001105) | 2.48825827 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.46511960 |
| 42 | Petechiae (HP:0000967) | 2.44182848 |
| 43 | Paraparesis (HP:0002385) | 2.43114818 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.42035202 |
| 45 | Fused cervical vertebrae (HP:0002949) | 2.41191856 |
| 46 | Mesangial abnormality (HP:0001966) | 2.39628171 |
| 47 | Ocular albinism (HP:0001107) | 2.38758212 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.31680541 |
| 49 | Abnormal hemoglobin (HP:0011902) | 2.29307285 |
| 50 | Spastic paraparesis (HP:0002313) | 2.28277252 |
| 51 | Purpura (HP:0000979) | 2.25853949 |
| 52 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.25694290 |
| 53 | Hypoplasia of the fovea (HP:0007750) | 2.25694290 |
| 54 | Ovoid vertebral bodies (HP:0003300) | 2.20682017 |
| 55 | Peritonitis (HP:0002586) | 2.19920280 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.18846737 |
| 57 | Cardiomegaly (HP:0001640) | 2.18078889 |
| 58 | Myositis (HP:0100614) | 2.17982005 |
| 59 | Amyloidosis (HP:0011034) | 2.16267578 |
| 60 | Gingivitis (HP:0000230) | 2.14941956 |
| 61 | Hepatosplenomegaly (HP:0001433) | 2.13789043 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.13758460 |
| 63 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.13644431 |
| 64 | Nephritis (HP:0000123) | 2.12917094 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.11256548 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11219328 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10292338 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.06614996 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.06321227 |
| 70 | Nonimmune hydrops fetalis (HP:0001790) | 2.04373424 |
| 71 | Albinism (HP:0001022) | 2.03994909 |
| 72 | Protrusio acetabuli (HP:0003179) | 2.03063454 |
| 73 | Metaphyseal irregularity (HP:0003025) | 2.02390957 |
| 74 | Iris hypopigmentation (HP:0007730) | 2.01447289 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 1.98753773 |
| 76 | Joint hemorrhage (HP:0005261) | 1.97440022 |
| 77 | Vascular calcification (HP:0004934) | 1.96280543 |
| 78 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.95791679 |
| 79 | Loss of speech (HP:0002371) | 1.95314710 |
| 80 | Orchitis (HP:0100796) | 1.94868295 |
| 81 | Hyperglycinuria (HP:0003108) | 1.94085036 |
| 82 | Myocardial infarction (HP:0001658) | 1.93145345 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92620373 |
| 84 | Partial duplication of thumb phalanx (HP:0009944) | 1.92581227 |
| 85 | Zonular cataract (HP:0010920) | 1.92037934 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 1.91874013 |
| 87 | Pathologic fracture (HP:0002756) | 1.91721751 |
| 88 | Urticaria (HP:0001025) | 1.89876645 |
| 89 | Cardiovascular calcification (HP:0011915) | 1.88775912 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.88478087 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 1.88092478 |
| 92 | Hydroxyprolinuria (HP:0003080) | 1.88076361 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 1.88076361 |
| 94 | Mitral stenosis (HP:0001718) | 1.87949669 |
| 95 | Prolonged partial thromboplastin time (HP:0003645) | 1.86778455 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86704532 |
| 97 | Generalized aminoaciduria (HP:0002909) | 1.85957947 |
| 98 | Premature loss of primary teeth (HP:0006323) | 1.85763072 |
| 99 | Recurrent skin infections (HP:0001581) | 1.85597171 |
| 100 | Partial duplication of the phalanx of hand (HP:0009999) | 1.85590696 |
| 101 | Increased serum ferritin (HP:0003281) | 1.84584671 |
| 102 | Prolonged neonatal jaundice (HP:0006579) | 1.84220090 |
| 103 | Diminished motivation (HP:0000745) | 1.84151217 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 1.83498703 |
| 105 | Thoracic kyphosis (HP:0002942) | 1.83462487 |
| 106 | Beaking of vertebral bodies (HP:0004568) | 1.82253497 |
| 107 | Achilles tendon contracture (HP:0001771) | 1.80888020 |
| 108 | Intrahepatic cholestasis (HP:0001406) | 1.80535902 |
| 109 | Hypokinesia (HP:0002375) | 1.79706944 |
| 110 | Skin nodule (HP:0200036) | 1.79511500 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78620246 |
| 112 | Hematochezia (HP:0002573) | 1.77464891 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77251254 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 1.77251254 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77163093 |
| 116 | Apathy (HP:0000741) | 1.76203301 |
| 117 | Dementia (HP:0000726) | 1.76054410 |
| 118 | Testicular atrophy (HP:0000029) | 1.75108755 |
| 119 | Bone pain (HP:0002653) | 1.73984922 |
| 120 | Periodontitis (HP:0000704) | 1.73701938 |
| 121 | Abnormal trabecular bone morphology (HP:0100671) | 1.73306917 |
| 122 | Sparse eyelashes (HP:0000653) | 1.73061044 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.72771653 |
| 124 | Spondylolisthesis (HP:0003302) | 1.72731126 |
| 125 | Abnormality of the nasal mucosa (HP:0000433) | 1.71389793 |
| 126 | Peripheral demyelination (HP:0011096) | 1.68792473 |
| 127 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.68754375 |
| 128 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.68754375 |
| 129 | Abnormal protein glycosylation (HP:0012346) | 1.68754375 |
| 130 | Abnormal glycosylation (HP:0012345) | 1.68754375 |
| 131 | Neoplasm of head and neck (HP:0012288) | 1.68413276 |
| 132 | Esophageal neoplasm (HP:0100751) | 1.68413276 |
| 133 | Nasal polyposis (HP:0100582) | 1.67537584 |
| 134 | Elevated alkaline phosphatase (HP:0003155) | 1.66640448 |
| 135 | Abnormality of the fovea (HP:0000493) | 1.66197712 |
| 136 | Gout (HP:0001997) | 1.65981774 |
| 137 | Rough bone trabeculation (HP:0100670) | 1.65511650 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 1.63882783 |
| 139 | Nausea (HP:0002018) | 1.63518147 |
| 140 | Generalized hypopigmentation (HP:0007513) | 1.62863066 |
| 141 | Joint stiffness (HP:0001387) | 1.62444560 |
| 142 | Abnormality of the costochondral junction (HP:0000919) | 1.60935657 |
| 143 | Protuberant abdomen (HP:0001538) | 1.60764875 |
| 144 | Proximal tubulopathy (HP:0000114) | 1.57724346 |
| 145 | Xanthomatosis (HP:0000991) | 1.57688871 |
| 146 | Obstructive lung disease (HP:0006536) | 1.57531744 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.57531744 |
| 148 | Generalized amyotrophy (HP:0003700) | 1.56604276 |
| 149 | Microretrognathia (HP:0000308) | 1.56549968 |
| 150 | Restrictive lung disease (HP:0002091) | 1.56448408 |
| 151 | Glomerulonephritis (HP:0000099) | 1.55813860 |
| 152 | Abdominal distention (HP:0003270) | 1.55373994 |
| 153 | Anorexia (HP:0002039) | 1.54765673 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.53629591 |
| 155 | Gingival bleeding (HP:0000225) | 1.53356329 |
| 156 | 3-Methylglutaconic aciduria (HP:0003535) | 1.53119302 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.51816688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.20512364 |
| 2 | BLK | 3.27575812 |
| 3 | EPHA2 | 3.23608683 |
| 4 | CDK12 | 3.13477936 |
| 5 | IRAK3 | 2.95564923 |
| 6 | TGFBR2 | 2.76199754 |
| 7 | NME2 | 2.29166856 |
| 8 | GRK6 | 2.19651055 |
| 9 | TAOK2 | 2.15710365 |
| 10 | CSF1R | 2.10283018 |
| 11 | ACVR1B | 1.97574100 |
| 12 | STK10 | 1.96547191 |
| 13 | PIM2 | 1.93967528 |
| 14 | GRK1 | 1.88264559 |
| 15 | LIMK1 | 1.85378866 |
| 16 | TESK2 | 1.82515149 |
| 17 | VRK2 | 1.75910853 |
| 18 | ADRBK2 | 1.73800633 |
| 19 | RIPK1 | 1.70981897 |
| 20 | TBK1 | 1.70165317 |
| 21 | MAPKAPK3 | 1.68097001 |
| 22 | MAP4K1 | 1.66797663 |
| 23 | KIT | 1.65592395 |
| 24 | KDR | 1.62168821 |
| 25 | PAK4 | 1.61111288 |
| 26 | GRK5 | 1.57346742 |
| 27 | PDK2 | 1.57133371 |
| 28 | EPHB1 | 1.57102977 |
| 29 | TRIB3 | 1.53316293 |
| 30 | MST4 | 1.51981204 |
| 31 | MATK | 1.46106996 |
| 32 | BUB1 | 1.43705685 |
| 33 | IRAK4 | 1.39104451 |
| 34 | TYK2 | 1.35363911 |
| 35 | PBK | 1.31566144 |
| 36 | CSK | 1.31043981 |
| 37 | CAMK1D | 1.29507367 |
| 38 | IKBKB | 1.28809642 |
| 39 | ZAP70 | 1.27627290 |
| 40 | EPHB2 | 1.24217906 |
| 41 | PRKD2 | 1.23318140 |
| 42 | MAPK7 | 1.18996542 |
| 43 | NEK9 | 1.17108563 |
| 44 | TGFBR1 | 1.16802328 |
| 45 | CDC42BPA | 1.16352340 |
| 46 | MST1R | 1.15354320 |
| 47 | LRRK2 | 1.15230288 |
| 48 | BCKDK | 1.14937941 |
| 49 | PRKG2 | 1.10891094 |
| 50 | MOS | 1.10389478 |
| 51 | GRK7 | 1.09090129 |
| 52 | FGFR4 | 1.07801465 |
| 53 | TAOK3 | 1.05261826 |
| 54 | RPS6KA4 | 1.03700670 |
| 55 | MET | 0.99383000 |
| 56 | FGR | 0.96293766 |
| 57 | ICK | 0.95815483 |
| 58 | MAP3K14 | 0.95399320 |
| 59 | JAK3 | 0.94609200 |
| 60 | PDGFRA | 0.93498941 |
| 61 | AKT3 | 0.93379606 |
| 62 | EPHA3 | 0.93272991 |
| 63 | ITK | 0.92303891 |
| 64 | MARK3 | 0.92254965 |
| 65 | BMX | 0.87852783 |
| 66 | MAP3K3 | 0.87659436 |
| 67 | SIK1 | 0.86768652 |
| 68 | TIE1 | 0.85976785 |
| 69 | TYRO3 | 0.85373388 |
| 70 | IKBKE | 0.84346003 |
| 71 | PIK3CG | 0.83495932 |
| 72 | TTK | 0.82750510 |
| 73 | MAP2K2 | 0.82596150 |
| 74 | CAMKK2 | 0.82372259 |
| 75 | SIK3 | 0.81714799 |
| 76 | MAP2K6 | 0.80723177 |
| 77 | TAOK1 | 0.80189501 |
| 78 | ERBB4 | 0.79772286 |
| 79 | DDR2 | 0.78825588 |
| 80 | TXK | 0.75114437 |
| 81 | LMTK2 | 0.73033754 |
| 82 | CDK7 | 0.72022186 |
| 83 | PTK2 | 0.71102802 |
| 84 | TESK1 | 0.69838947 |
| 85 | JAK1 | 0.69731376 |
| 86 | GSK3A | 0.67493889 |
| 87 | TLK1 | 0.67221993 |
| 88 | EIF2AK2 | 0.64749272 |
| 89 | SMG1 | 0.60192325 |
| 90 | BTK | 0.59131557 |
| 91 | PRKCD | 0.57293368 |
| 92 | RPS6KA2 | 0.57203919 |
| 93 | ABL2 | 0.56617296 |
| 94 | PIM1 | 0.55722513 |
| 95 | PRPF4B | 0.55694518 |
| 96 | WNK1 | 0.54487047 |
| 97 | LYN | 0.54460776 |
| 98 | HCK | 0.54007187 |
| 99 | MAP3K12 | 0.53337602 |
| 100 | FLT3 | 0.53309149 |
| 101 | TEC | 0.52610085 |
| 102 | PDPK1 | 0.52572226 |
| 103 | LCK | 0.52502488 |
| 104 | EIF2AK1 | 0.51612909 |
| 105 | IRAK1 | 0.50168054 |
| 106 | FGFR3 | 0.49842799 |
| 107 | MAPK15 | 0.49462165 |
| 108 | CAMK1G | 0.48390657 |
| 109 | NUAK1 | 0.48336445 |
| 110 | PAK1 | 0.48066144 |
| 111 | EIF2AK3 | 0.47238503 |
| 112 | CHUK | 0.47019782 |
| 113 | MYLK | 0.46938048 |
| 114 | TNK2 | 0.46512205 |
| 115 | MAP3K11 | 0.46452664 |
| 116 | IGF1R | 0.46269475 |
| 117 | NLK | 0.45627896 |
| 118 | PTK6 | 0.44401496 |
| 119 | TRPM7 | 0.42798975 |
| 120 | PRKCI | 0.40212353 |
| 121 | HIPK2 | 0.39582098 |
| 122 | MAPKAPK2 | 0.39034673 |
| 123 | MAP3K1 | 0.38481418 |
| 124 | IRAK2 | 0.37459890 |
| 125 | MAP2K3 | 0.36760993 |
| 126 | MAP3K8 | 0.36244437 |
| 127 | SYK | 0.33681757 |
| 128 | ABL1 | 0.33542313 |
| 129 | JAK2 | 0.33396830 |
| 130 | ILK | 0.31212607 |
| 131 | ADRBK1 | 0.30581772 |
| 132 | MAPK12 | 0.30320627 |
| 133 | PINK1 | 0.29886120 |
| 134 | DAPK3 | 0.29490779 |
| 135 | RPS6KL1 | 0.29470354 |
| 136 | RPS6KC1 | 0.29470354 |
| 137 | STK16 | 0.29357440 |
| 138 | ARAF | 0.29202515 |
| 139 | CSNK1G3 | 0.28794066 |
| 140 | CAMK4 | 0.28696103 |
| 141 | EGFR | 0.27891837 |
| 142 | RPS6KA6 | 0.26607699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.67218751 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.20805261 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.12575539 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.03392074 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55748870 |
| 6 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.44392435 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.40716596 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.10203192 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96195738 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87144538 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.84016973 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74181702 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66442919 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66266726 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.63907657 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.54372774 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50420054 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48725457 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.44805529 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42236976 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40687541 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.30085423 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.29197310 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28611406 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26207245 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18811342 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18607212 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17785161 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.17509718 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16813708 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.16656499 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13029353 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12504841 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11619394 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11232456 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11042289 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09796552 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08770543 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07675752 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04596139 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.02633604 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01507300 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99154245 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99055843 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.96449376 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.96319272 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95472248 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94700740 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94162647 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92530244 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91944588 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91790230 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91586004 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91511383 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.91200562 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90121839 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89282206 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84797663 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83815496 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81561979 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79666460 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.78605743 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78084903 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77165120 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73848241 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.72625485 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72615056 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72108438 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71526813 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71038095 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69522487 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69439105 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68022904 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.67930465 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67469235 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.67431059 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66339252 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65277333 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65071534 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64404817 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62602210 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62417915 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61689615 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61058644 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61025625 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60542322 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59311101 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59128216 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59088545 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.58796724 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.57141568 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.55852863 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55685372 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54220969 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.54192472 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52858381 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52850600 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51515472 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51485575 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.51400452 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.50127664 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49633478 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48818356 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48620843 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48016521 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.47378278 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47039620 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46594436 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46041055 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45089124 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44865338 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43613731 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43542033 |
| 114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42315507 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42252830 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41473267 |
| 117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41278129 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40828961 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40017314 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39968840 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39439091 |
| 122 | Asthma_Homo sapiens_hsa05310 | 0.38668422 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38621644 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38463042 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38373366 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38212922 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38039750 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34342532 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32828569 |

